Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Amazon stock fells despite stronger-than-expected Q4 earnings. The tech giant's guidance for the current quarter missed views ...

Fourth-quarter results beat Wall Street estimates but the company’s revenue outlook for the first quarter fell shy of ...

Fortinet forecast its full-year revenue above Wall Street estimates on Thursday, as clients turn to its cybersecurity products to protect their digital operations from rising online threats. The ...

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

Rivian has made its all-electric commercial van available for sale to the general public after years of it being only ...

The Dow Jones rose Thursday after surprise weekly jobless claims. Nvidia partner Arm stock tumbled on earnings, while Roblox ...

Dow Jones rose on Thursday while the S&P 500 and the Nasdaq built more support at the 50-day moving average in the stock ...

The company reported fiscal third-quarter adjusted earnings per share of 39 cents, compared with Wall Street’s consensus ...

Britain's central bank cut its main interest rate in response to a troubling mix of stuttering growth, stubborn inflation and ...

Consumers are snapping up expensive handbags and other goods—when brands deliver what they want. Shares in Tapestry (TPR) ...

Software maker Salesforce named named a board of directors member, Robin Washington, as its new CFO and COO. Current COO ...